MetLife, Inc.:企業の戦略・SWOT・財務情報

◆英語タイトル:MetLife, Inc. - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C15545
◆発行会社(調査会社):MarketLine
◆発行日:2019年3月
◆ページ数:63
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:サービス
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥23,275見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥46,550見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥69,825見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

MetLife, Inc. – Strategy, SWOT and Corporate Finance Report
Summary

MetLife, Inc. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

MetLife, Inc. (MetLife) is a provider of insurance, employee benefits, annuities and asset management products and services. It offer insurance products for term life, variable life, universal life, dental, vision and accident and health, group short- and long-term disability, individual disability, critical illness, and accidental death and dismemberment. It also offers prepaid legal plans, retirement and income solutions, and personal and commercial lines of property and casualty insurance, including small business owners’ insurance, homeowners’ insurance and auto insurance. The company markets and sells its products and services to individuals; corporations and their respective employees and other institutions and their respective members through independent agencies, brokerage firms, sales offices, direct marketing, career agency, bancassurance, other third-party distribution and e-commerce channel. Its operations are spanned across the US, Asia, Europe, Japan, Latin America and the Middle East. MetLife is headquartered in New York, the US.

The company reported direct premium of US$39,595 million during FY2017, an increase of 4.3% over FY2016. Its net premium was US$38,992 million in FY2017, an increase of 4.8% over FY2016.

Scope

- Detailed information on MetLife, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting MetLife, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of MetLife, Inc. including a breakdown and examination of key business segments
- Intelligence on MetLife, Inc.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about MetLife, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of MetLife, Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess MetLife, Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on MetLife, Inc.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
MetLife, Inc.: Company Overview
MetLife, Inc.: Overview and Key Facts
MetLife, Inc.: Overview
MetLife, Inc.: Key Facts
MetLife, Inc.: Key Employees
MetLife, Inc.: Key Employee Biographies
MetLife, Inc.: Major Products and Services
MetLife, Inc.: Company History
MetLife, Inc.: Management Statement
MetLife, Inc.: Locations and Subsidiaries
MetLife, Inc.: Key Competitors
MetLife, Inc.: Company Analysis
MetLife, Inc.: Business Description
MetLife, Inc.: SWOT Analysis
MetLife, Inc.: SWOT Overview
MetLife, Inc.: Strengths
MetLife, Inc.: Weaknesses
MetLife, Inc.: Opportunities
MetLife, Inc.: Threats
MetLife, Inc.: Corporate Financial Deals Activity
MetLife, Inc.: Financial Deals Overview
MetLife, Inc.: Targets and Partners
MetLife, Inc.: Top Deals 2015 – 2019YTD*
MetLife, Inc.: Advisors
MetLife, Inc.: Top Legal Advisors
MetLife, Inc.: Top Financial Advisors
MetLife, Inc.: Mergers and Acquisitions
MetLife, Inc.: Corporate Venturing
MetLife, Inc.: Capital Raising
MetLife, Inc.: Partnership
MetLife, Inc.: Divestments
MetLife, Inc.: Recent Developments
MetLife, Inc.: News and Events Summary
MetLife, Inc.: Business Expansion
MetLife, Inc.: Business Reorganization
MetLife, Inc.: Contracts
MetLife, Inc.: Corporate Governance
MetLife, Inc.: Financial Performance
MetLife, Inc.: Market Developments
MetLife, Inc.: Regulatory and Legal Events
MetLife, Inc.: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: MetLife, Inc.: Key Facts
Table 2: MetLife, Inc.: Key Employees
Table 3: MetLife, Inc.: Company History
Table 4: MetLife, Inc.: Locations and Subsidiaries
Table 5: MetLife, Inc.: Key Competitors
Table 6: MetLife, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 7: MetLife, Inc.: Deal Activity by Deal Type - Volume (2015 - YTD*2019)
Table 8: MetLife, Inc.: M&A Average Deal Size - Value (US$m)
Table 9: MetLife, Inc.: Targets and Partners
Table 10: MetLife, Inc.: Top Deals 2015 - 2019YTD*
Table 11: MetLife, Inc.: Legal Advisor Ranking by Value (US$m)
Table 12: MetLife, Inc.: Financial Advisor Ranking by Value (US$m)
Table 13: MetLife, Inc.: M&A Volume and Value Trend (2015 - YTD*2019)
Table 14: MetLife, Inc.: M&A Activity by Geography (2015 - YTD*2019)
Table 15: MetLife, Inc.: Corporate Venturing Volume and Value Trend (2015 - YTD*2019)
Table 16: MetLife, Inc.: Corporate Venturing by Geography (2015 - YTD*2019)
Table 17: MetLife, Inc.: Capital Raising Volume and Value Trend (2015 - YTD*2019)
Table 18: MetLife, Inc.: Capital Raising by Deal Type (2015 - YTD*2019)
Table 19: MetLife, Inc.: Partnership Volume and Value Trend (2015 - YTD*2019)
Table 20: MetLife, Inc.: Partnership Trend by Deal Type (2015 - YTD*2019)
Table 21: MetLife, Inc.: Divestments Volume and Value Trend (2015 - YTD*2019)
Table 22: MetLife, Inc.: Divestments by Geography (2015 - YTD*2019)
Table 23: MetLife, Inc.: News and Events Summary
Table 24: MetLife, Inc.: Business Expansion
Table 25: MetLife, Inc.: Business Reorganization
Table 26: MetLife, Inc.: Contracts
Table 27: MetLife, Inc.: Corporate Governance
Table 28: MetLife, Inc.: Financial Performance
Table 29: MetLife, Inc.: Market Developments
Table 30: MetLife, Inc.: Regulatory and Legal Events
Table 31: MetLife, Inc.: Strategy and Operations

List of Figures
Figure 1: MetLife, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: MetLife, Inc.: Deal Activity by Deal Type - Volume (2015 - YTD*2019)
Figure 3: MetLife, Inc.: M&A Average Deal Size - Value (US$m)
Figure 4: MetLife, Inc.: M&A Volume and Value Trend (2015 - YTD*2019)
Figure 5: MetLife, Inc.: M&A Activity by Geography (2015 - YTD*2019)
Figure 6: MetLife, Inc.: Corporate Venturing Volume and Value Trend (2015 - YTD*2019)
Figure 7: MetLife, Inc.: Corporate Venturing by Geography (2015 - YTD*2019)
Figure 8: MetLife, Inc.: Capital Raising Volume and Value Trend (2015 - YTD*2019)
Figure 9: MetLife, Inc.: Capital Raising by Deal Type (2015 - YTD*2019)
Figure 10: MetLife, Inc.: Partnership Volume and Value Trend (2015 - YTD*2019)
Figure 11: MetLife, Inc.: Partnership Trend by Deal Type (2015 - YTD*2019)
Figure 12: MetLife, Inc.: Divestments Volume and Value Trend (2015 - YTD*2019)
Figure 13: MetLife, Inc.: Divestments by Geography (2015 - YTD*2019)

★海外企業調査レポート[MetLife, Inc.:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • BB&T Corporation:企業の戦略・SWOT・財務情報
    BB&T Corporation - Strategy, SWOT and Corporate Finance Report Summary BB&T Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • ADMA Biologics Inc (ADMA):企業の財務・戦略的SWOT分析
    ADMA Biologics Inc (ADMA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Seabridge Gold Inc.:企業のM&A・事業提携・投資動向
    Seabridge Gold Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Seabridge Gold Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • Olympus Corporation:企業の戦略・SWOT・財務分析
    Olympus Corporation - Strategy, SWOT and Corporate Finance Report Summary Olympus Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Global Orthopaedic Technology Pty Ltd-医療機器分野:企業M&A・提携分析
    Summary Global Orthopaedic Technology Pty Ltd (Global) is an orthopaedic implant designer and manufacturer. The company offers orthopaedic implants for knee, hip and spine. Its hip products include global cup, bioball system, paragon stem, absolut cemented stem, and unisyn hip system among others. I …
  • Elders Limited:企業のM&A・事業提携・投資動向
    Elders Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Elders Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • Ryman Healthcare Ltd (RYM):企業の財務・戦略的SWOT分析
    Ryman Healthcare Ltd (RYM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Tanita Corp:企業の戦略的SWOT分析
    Tanita Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Origin Energy Ltd (ORG):電力:M&Aディール及び事業提携情報
    Summary Origin Energy Ltd (Origin Energy) is an integrated energy company. It generates, supplies and distributes electricity; explores and develops natural gas reserves; and produces and sells gas. The company generates electricity from natural-gas fired, coal-fired, wind, solar, pumped water stora …
  • Sammons Enterprises Inc:戦略・SWOT・企業財務分析
    Sammons Enterprises Inc - Strategy, SWOT and Corporate Finance Report Summary Sammons Enterprises Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Boursorama Sa:企業の戦略・SWOT・財務分析
    Boursorama Sa - Strategy, SWOT and Corporate Finance Report Summary Boursorama Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • TWi Pharmaceuticals Inc (4180)-製薬・医療分野:企業M&A・提携分析
    Summary TWi Pharmaceuticals Inc (TWi), formerly Anchen Pharmaceuticals (Taiwan) Inc is a manufacturer of high barrier generics drugs. The company’s products include donepezil hydrochloride tablets, hydroquinone cream, hydroquinone time release cream, megestrol acetate oral suspension and nifedipine …
  • Canadian Tire Corp Ltd (CTC.A):企業の財務・戦略的SWOT分析
    Canadian Tire Corp Ltd (CTC.A) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • CJ O Shopping Co.,Ltd (035760):企業の財務・戦略的SWOT分析
    CJ O Shopping Co.,Ltd (035760) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Aarhus University-製薬・医療分野:企業M&A・提携分析
    Summary Aarhus University (Aarhus) is a university that undertakes activities related to research, talent development, knowledge exchange and education. The university offers bachelor’s degree programmes, master’s degree programmes and PhD programmes in various disciplines. Its areas of academic int …
  • Deoleo, S.A.:企業の戦略・SWOT・財務情報
    Deoleo, S.A. - Strategy, SWOT and Corporate Finance Report Summary Deoleo, S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Randstad Holding NV (RAND):企業の財務・戦略的SWOT分析
    Randstad Holding NV (RAND) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Spark Therapeutics Inc (ONCE):企業の財務・戦略的SWOT分析
    Summary Spark Therapeutics Inc (Spark) is a clinical-stage gene therapy company which provides gene therapies for inherited retinal diseases (IRDs), neurodegenerative diseases, as well as liver diseases. Its pipeline products include SPK-RPE65, SPK-CHM, rhonova, LHON, SPK-FIX, SPK-FVIII and SPK-TPP1 …
  • Globeimmune Inc (GBIM):企業の財務・戦略的SWOT分析
    Summary Globeimmune Inc (Globeimmune) is a biopharmaceutical company that develops therapeutic products for treatment of cancer and infectious diseases. The company provides products for infectious disease and oncology. It offers oncology products such as GI-4000, GI-6207 and GI-6301. Globeimmune pr …
  • Aalberts Industries NV:企業のM&A・事業提携・投資動向
    Aalberts Industries NV - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Aalberts Industries NV Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆